Assistant Professor Julius Fredens (right) and first author Mr Ong Shujian (left) from NUS SynCTI reviewing experimental data from studies that optimize gene functions. (Credit: National University of Singapore)
Lab-Engineered Virus Drives Bacterial Evolution 160,000 Times Faster Than Normal
In A Nutshell
- Researchers at the National University of Singapore engineered a bacteria-killing virus into a precision mutation machine that can evolve bacterial genes in roughly a day, far faster than standard lab methods.
- Called LySE, the system deliberately floods target genes with copying errors at rates up to 160,000 times higher than normal, while leaving the rest of the bacterial DNA untouched.
- In lab tests, LySE evolved 25 times greater antibiotic tolerance in just five cycles, outperforming a conventional comparison method that produced gains that vanished when moved to fresh bacteria.
- Unlike most competing platforms, LySE requires only basic lab equipment and could eventually help scientists engineer bacteria for applications ranging from studying drug resistance to processing plastic-linked compounds.
A virus that kills bacteria in 17 minutes is now being used to speed up evolution itself. Researchers at the National University of Singapore have turned a bacteria-infecting virus into a turbocharged mutation engine, compressing weeks of laboratory work into roughly a day-long cycle. Called lytic selection and evolution (LySE), the method could change how scientists engineer bacteria to study drug resistance, improve metabolic pathways, and one day support applications from plastic-linked recycling processes to medicine production.
At its core, the system exploits bacteriophage T7, a tiny virus that naturally hunts E. coli bacteria, copies itself inside the cell, and bursts out in about 17 minutes, releasing roughly 180 new viral particles in the process. Most viruses try to copy DNA as accurately as possible. LySE does the opposite.
Researchers rewired T7’s DNA-copying machinery to make deliberate, targeted errors at extraordinarily high rates, flooding specific genes with copying mistakes while leaving the rest of the bacterial DNA untouched. That precision lets the team evolve chosen genetic traits at speeds far beyond what standard lab methods can achieve.
How LySE Outpaces Standard Evolution Methods
For decades, scientists have used a process called directed evolution to engineer proteins and biological pathways. In the classic approach, researchers manually introduce random mutations into a gene, test which versions perform best, and repeat the cycle. It works, but it is slow and labor-intensive. Newer, automated “continuous” methods run without human intervention, but they lose control: mutations accumulate in the wrong places, and cells sometimes find shortcuts, called cheater mutations, that game the system without actually improving the target gene.
LySE splits the difference. During each cycle, the system alternates between two phases. In the lytic phase, T7 viruses infect bacteria at a high ratio, triggering an error-prone copying process that churns out mutated versions of the target genes and packages them into new viral particles. In the cellular phase, those particles deliver the mutated genes to fresh, uninfected bacteria at a low ratio, where the bacteria grow and compete. Only cells carrying improved gene variants survive whatever pressure the researchers have applied, whether that is an antibiotic or a difficult food source. Critically, the old bacterial hosts are completely destroyed during the lytic phase, wiping out any stray mutations that may have built up elsewhere in the bacterial DNA. Each new cycle starts with a clean slate.
Inside the Broken Copying Machine
Engineering the mutation engine at the heart of LySE took multiple rounds of modification. Researchers started with a previously known error-prone version of T7’s DNA-copying enzyme and stacked additional changes on top of one another to make it progressively sloppier.
Early variants reached mutation rates roughly 70 times higher than the normal enzyme. From there, the team disabled the enzyme’s error-catching function entirely and fused it to a protein that chemically alters DNA letters as they are being copied. One intermediate version, called v8, reached a mutation rate approximately 160,000 times higher than the baseline rate seen in the host E. coli genome. A refined final version, v9, had a somewhat lower but still very high mutation rate while maintaining better viral packaging efficiency, making it the better practical choice for running LySE campaigns.
Both versions favored one broad class of DNA changes, called transitions (where one DNA letter swaps for a chemically similar one), rather than producing every possible single-letter change equally. Within that constraint, mutations were spread evenly across the full target sequence, with no obvious hot spots or dead zones.
An elegant side effect of making the copying enzyme so error-prone was an automatic safety feature the researchers call multiplicity tuning. Because the error-prone enzyme sabotages its own replication, widespread bacterial killing only occurs when researchers deliberately add a large number of viral particles relative to bacteria. Dialing that ratio up or down gives precise control over when each phase of the cycle begins, with no genetic switches or chemical triggers required.
From Drug Resistance Genes to Plastic-Linked Pathways
To test the system, the researchers ran two experiments. First, they evolved a gene called tetA, which confers resistance to the antibiotic tetracycline, to instead resist tigecycline, a more powerful antibiotic that normally defeats tetA-based defenses. After five LySE cycles, the evolved bacteria tolerated 25 times more tigecycline than bacteria with the original gene. A standard comparison method, adaptive laboratory evolution, reached only a fraction of that improvement over the same number of rounds, and those gains largely disappeared when the evolved gene was moved to fresh bacteria.
In a second test, the team evolved a five-gene pathway that allows E. coli to use ethylene glycol, a chemical building block released when PET plastic is broken down, as its sole food source. After five LySE cycles, the best-performing bacterial strains showed a 50.9% increase in final cell density compared to the starting version, according to the study published in Nature Microbiology. Bacteria evolved by the comparison method showed no mutations in the target genes at all; their gains came entirely from changes elsewhere in the genome.
LySE requires nothing beyond standard lab tools: pipettes, culture tubes, and an incubator. It may also handle genetic packages far larger than most competing methods allow, opening the door to evolving multi-gene pathways that have long been out of reach for rapid directed evolution.
Paper Notes
Limitations
LySE was demonstrated only in E. coli hosts that bacteriophage T7 can infect, which limits the organisms in which it can be directly applied. While the T7 capsid can theoretically carry genetic packages approaching 40,000 DNA letters, the largest construct actually evolved under selection in this study was approximately 9,715 letters; a 29-kb construct was transduced but not evolved under selection. Mutations can also accumulate in non-target regions of the phagemid, as was observed in one of five clones that showed accelerated growth on ethylene glycol. The mutation spectrum of v9 still shows a clear bias toward one class of DNA changes, transitions, meaning not all possible mutations are equally accessible. Effective library size depends on growth vessel volume and packaging efficiency, both of which decline at the highest error rates. LySE’s generation time may also be longer than some competing continuous systems, though it accommodates slow-appearing traits that create bottlenecks in faster platforms.
Funding and Disclosures
This work was supported by National University of Singapore funding, including the NUS Presidential Young Professorship and the National Centre for Engineering Biology, as well as Singapore National Research Foundation support through a Research Fellowship and additional grants. The authors declare no competing interests. NUS has filed a patent application covering LySE (PCT/SG2025/050734).
Publication Details
Title: Bridging continuous and discrete evolution through a controllable, hypermutagenic phage-bacteria system | Authors: Shujian Ong, Pramila Ghode, Ashvinath Narenderan, Shuxuan Lao, Fabian Willenborg, Tobias V. Eden, Carl O. Marsh, Wen Shan Yew, and Julius Fredens | Journal: Nature Microbiology | DOI: https://doi.org/10.1038/s41564-026-02346-y | Received: June 4, 2025; Accepted: April 1, 2026 | Corresponding author: Julius Fredens ([email protected])







